Skip to main content
. 2011 Oct 27;27(4):413–419. doi: 10.1007/s11606-011-1888-1

Table 2.

Follow-up Time, Treatment Intensification and Intervention Exposure by Number of Clinic Follow-up Visits

Number of visits to clinic Number (%) of patients Follow-up time (months)* Number of treatment intensifications (dose increase or addition of a drug) Number (%) of patients referred for an uncertainty reduction intervention (intervention group only)‡
IC UCC IC UCC IC UCC ABPM§ MEMS || Lifestyle¶ Any Referral
1 14 (4) 17 (5) 0 0 0.5 ± 0.52 0.3 ± 0.5 1 (7) 0 0 1
2–3 36 (11) 59 (17) 11.8 ± 9.3 12.9 ± 10.3 0.9 ± 0.77 0.6 ± 0.6 6 (17) 5 (14) 8 (22) 12 (27)
4–5 60 (19) 65 (19) 17.9 ± 8.7 16.9 ± 7.7 1.3 ± 1.0 0.9 ± 0.8 10 (17) 8 (13) 14 (23) 19 (31)
6–9 117 (37) 142 (41) 22.7 ± 5.1 23.5 ± 5.2 1.7 ± 1.2 1.3 ± 1.3 29 (25) 31 (25) 32 (27) 57 (49)
≥10 84 (26) 62 (18) 24.5 ± 4.2 24.9 ± 4.5 2.8 ± 2.1 2.2 ±1.7 26 (31) 26 (31) 31 (37) 42 (50)
Column total or overall mean 320 345 19.8 ± 8.7 19.5 ± 9.1 1.8 ± 1.5 1.3 ± 1.5 72 (23) 70 (22) 85 (27) 131 (40)

*p = 09 for overall mean follow-up months

p < 0.001 for overall mean difference

‡Denominator for percents = 320

§25% controlled

||71% adherent (≥80% of prescribed doses taken)

¶45 (53%) had high fat diet pattern; 76(89%) had low fruit/vegetable intake; 60 (71%) had sedentary lifestyle; 18 (21%) smoked